Genmab’s 25th Anniversary
From Where We Started to Where We are Going
February 25 marks Genmab’s 25th anniversary.
Over the past quarter-century, Genmab has emerged as a scientific leader in antibody research, working towards the goal of pioneering and revolutionizing the way we treat cancer and other serious diseases.
Since our founding in 1999, innovative science has been our core, as we strive to create medicines that have never been made before for patients with limited treatment options facing cancer and other serious diseases.
Today, our innovations power eight approved antibody-based medicines and our workforce has grown from 10 to 2,100+ people internationally.